NCT00493402View on ClinicalTrials.gov

Different Regimens of Transarterial Chemoembolization for Hepatocellular Carcinoma

PHASE3CompletedINTERVENTIONAL
Enrollment

365

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Hepatocellular Carcinoma
Interventions
PROCEDURE

Transarterial chemoembolization (TACE)

drugs and dosage: chemotherapy with lipiodol mixed with EADM 50mg, lobaplatin 50mg, and MMC 6mg, plus particle embolization.

PROCEDURE

Transarterial chemoembolization (TACE)

drugs and dosage: chemotherapy with lipiodol mixed with EADM 50mg, lobaplatin 50mg, and MMC 6mg.

PROCEDURE

Transarterial chemoembolization (TACE)

Drugs and dosage:chemotherapy with lipiodol mixed with EADM 50mg, plus particle embolization.

Trial Locations (1)

510060

Cancer Center Sun Yat-sen University, Guangzhou

All Listed Sponsors
collaborator

Ministry of Health, China

OTHER_GOV

collaborator

Guangdong Provincial People's Hospital

OTHER

collaborator

The 458 Hospital of Chinese PLA

OTHER

collaborator

Kaiping Central Hospital

OTHER

lead

Sun Yat-sen University

OTHER

NCT00493402 - Different Regimens of Transarterial Chemoembolization for Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter